{"altmetric_id":18180840,"counts":{"readers":{"mendeley":82,"citeulike":0,"connotea":0},"total":{"posts_count":2},"blogs":{"unique_users_count":1,"unique_users":[55276],"posts_count":1},"policy":{"unique_users_count":1,"unique_users":["rijksoverheid"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4e83cf058f61000227a","authors":["Takahiro Higashi","Paul G. Shekelle","David H. Solomon","Eric L. Knight","Carol Roth","John T. Chang","Caren J. Kamberg","Catherine H. MacLean","Roy T. Young","John Adams","David B. Reuben","Jerry Avorn","Neil S. Wenger"],"doi":"10.7326\/0003-4819-140-9-200405040-00011","first_seen_on":"2017-03-28T04:34:05+00:00","issns":["0003-4819"],"journal":"Annals of Internal Medicine","last_mentioned_on":1387314000,"links":["http:\/\/dx.doi.org\/10.7326\/0003-4819-140-9-200405040-00011"],"pdf_url":"http:\/\/annals.org\/data\/journals\/aim\/20064\/0000605-200405040-00011.pdf","pubdate":"2004-05-04T00:00:00+00:00","publisher":"American College of Physicians","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"title":"The Quality of Pharmacologic Care for Vulnerable Older Patients","type":"article","uri":"http:\/\/annals.org\/article.aspx?doi=10.7326\/0003-4819-140-9-200405040-00011","mendeley_url":"http:\/\/www.mendeley.com\/research\/quality-pharmacologic-care-vulnerable-older-patients"},"altmetric_score":{"score":8.136,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":8.136},"context_for_score":{"all":{"total_number_of_other_articles":7762368,"mean":6.6348441760037,"rank":953219,"this_scored_higher_than_pct":87,"this_scored_higher_than":6809129,"rank_type":"exact","sample_size":7762368,"percentile":87},"similar_age_3m":{"total_number_of_other_articles":217579,"mean":12.78446737262,"rank":40081,"this_scored_higher_than_pct":81,"this_scored_higher_than":177495,"rank_type":"exact","sample_size":217579,"percentile":81},"this_journal":{"total_number_of_other_articles":7480,"mean":25.654091723492,"rank":2368,"this_scored_higher_than_pct":68,"this_scored_higher_than":5094,"rank_type":"exact","sample_size":7480,"percentile":68},"similar_age_this_journal_3m":{"total_number_of_other_articles":156,"mean":97.481883870968,"rank":99,"this_scored_higher_than_pct":36,"this_scored_higher_than":57,"rank_type":"exact","sample_size":156,"percentile":36}}},"demographics":{"users":{"mendeley":{"by_status":{"Unspecified":2,"Professor > Associate Professor":5,"Librarian":2,"Researcher":18,"Student  > Doctoral Student":3,"Student  > Ph. D. Student":14,"Student  > Postgraduate":9,"Student  > Master":10,"Other":9,"Student  > Bachelor":5,"Lecturer":2,"Lecturer > Senior Lecturer":1,"Professor":2},"by_discipline":{"Medicine and Dentistry":50,"Social Sciences":6,"Physics and Astronomy":1,"Psychology":9,"Immunology and Microbiology":1,"Economics, Econometrics and Finance":3,"Agricultural and Biological Sciences":4,"Nursing and Health Professions":2,"Business, Management and Accounting":1,"Unspecified":3,"Pharmacology, Toxicology and Pharmaceutical Science":2}}},"geo":{"mendeley":{"CA":1,"NL":1,"US":3,"BR":2,"GB":1,"ES":3,"IN":1}}},"posts":{"blogs":[{"title":"Calcium-Channel Blocker-Clarithromycin Drug Interactions and Acute Kidney Injury","url":"http:\/\/dx.doi.org\/10.1001\/jama.2013.282426","license":"public","citation_ids":[18180737,18180737,6188732,18180742,1562816,1562816,18180745,18180751,18180751,18180758,1230528,1230528,18180766,18180769,18180776,18180782,1907350,1907350,18180794,18180794,770437,770437,18180801,18180801,1346262,1346262,18180808,700131,3239872,1290223,1290223,543108,543108,808076,808076,18180814,1636503,1636503,1247081,1247081,18180817,18180820,15063154,15063154,18180823,1341709,1341709,2584175,1595693,1630845,16194411,4580865,4580865,18180829,18180831,18180835,18180840],"posted_on":"2013-12-17T21:00:00+00:00","summary":"Interview with Amit X. Garg, MD, PhD, author of Calcium-Channel Blocker-Clarithromycin Drug Interactions and Acute Kidney Injury","author":{"name":"JAMA Author Interviews","url":"http:\/\/jama.jamanetwork.com\/multimedia.aspx#AuthorInterviews","description":"Interviews with Authors of JAMA Articles"}}],"policy":[{"title":"Tijd en toekomst - Kamerstuk - Rijksoverheid.nl","url":"https:\/\/www.rijksoverheid.nl\/binaries\/rijksoverheid\/documenten\/kamerstukken\/2010\/03\/17\/tijd-en-toekomst\/pg-2994520f.pdf","license":"public","citation_ids":[20518634,3428075,20518635,3190558,144981,15399364,7656720,118855,20518637,7866116,2483905,7430821,454300,247498,20518639,3440781,8227629,3675431,20518640,20518641,2742715,20518643,7396738,2034438,200731,20518646,14712681,2547115,20518647,20518648,3190576,16288350,4633046,4000088,7414865,9766309,18180840,15735469,3190604,16027293,3219685,16391565,426084,1291936,3211467,20518652,20518653],"posted_on":"2010-03-31T13:35:00+00:00","source":{"name":"rijksoverheid.nl","description":"rijksoverheid.nl is a searchable database of documents produced by the Dutch government.","geo":{"country":"NL"}},"page_url":"https:\/\/www.rijksoverheid.nl\/documenten\/kamerstukken\/2010\/03\/17\/tijd-en-toekomst","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-f150de14715133099809fed75bb53d9d38aac3eea6efa5a92b896e6cc0c78e14.jpg"}}]}}